China Resources Pharmaceutical Group Limited

HKEX:3320.HK

5.35 (HKD) • At close August 1, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q4
Revenue 137,345.6139,351.412130,461.189138,940.062128,389.889125,716.477122,318.563114,487.606111,035.88189,387.142102,530.908101,922.96195,948.30493,740.80389,794.60682,737.59881,089.6875,615.52375,305.22771,262.87836,642.02667,874.5967,874.5958,475.34829,237.674
Cost of Revenue 116,324.492116,667.377110,594.26116,599.396109,086.81105,884.796104,403.34897,022.53593,608.84274,520.3285,946.80184,489.37877,899.30376,859.42574,046.4370,209.62668,733.69163,862.41363,563.00959,806.23430,842.31157,129.57957,129.57948,400.80624,200.403
Gross Profit 21,021.10822,684.03519,866.92922,340.66619,303.07919,831.68117,915.21517,465.07117,427.03914,866.82216,584.10717,433.58318,049.00116,881.37815,748.17612,527.97212,355.98911,753.1111,742.21811,456.6445,799.71610,745.01110,745.01110,074.5435,037.271
Gross Profit Ratio 0.1530.1630.1520.1610.150.1580.1460.1530.1570.1660.1620.1710.1880.180.1750.1510.1520.1550.1560.1610.1580.1580.1580.1720.172
Reseach & Development Expenses 1,139.4521,017.5381,665.338947.0591,300.199789.319996.133692.418862.787455.177655.325498.968648.714390.566604.252303.924428.119361.297508.269272.87500000
General & Administrative Expenses 3,918.973,271.2963,742.6993,212.6493,377.572,932.7523,526.532,701.1173,414.9672,148.1852,861.7042,342.0642,563.5762,140.032,423.6371,778.12,138.3751,743.8112,115.2731,729.619961.2232,123.3872,123.3871,836.753918.376
Selling & Marketing Expenses 11,099.85110,077.35310,382.00310,436.0059,467.9729,077.1839,247.7018,282.9999,259.746,769.70510,274.0598,914.4649,900.4458,440.4358,357.6415,511.1445,979.2314,968.2485,497.4014,614.1452,527.8874,400.0774,400.0774,211.5582,105.779
SG&A 15,037.18514,101.20614,146.7714,358.00313,816.18812,416.57513,080.22311,362.66613,107.9979,397.34813,380.2911,458.38812,553.84410,580.46510,826.627,289.2448,117.6066,712.0597,612.6746,343.7643,489.116,523.4646,523.4646,048.313,024.155
Other Expenses 000000000000000000-3,689.7-3,148.32-3,148.32-6,080.443-6,080.443-5,825.551-2,912.776
Operating Expenses 16,176.63715,118.74415,496.90615,305.06215,116.38713,205.89414,076.35612,055.08413,970.7849,852.52514,035.61511,957.35612,776.69510,492.89410,653.0087,224.497,604.2256,704.2227,729.7035,558.071340.789443.021443.021222.759111.38
Operating Income 4,844.4717,565.2924,252.7957,035.6044,186.6926,625.7873,838.8595,409.9873,456.2555,014.2972,548.4925,476.2274,787.5275,656.6934,389.8054,897.693,834.84,488.1323,170.0654,709.2021,717.153,105.7213,105.7212,934.2691,467.134
Operating Income Ratio 0.0350.0540.0330.0510.0330.0530.0310.0470.0310.0560.0250.0540.050.060.0490.0590.0470.0590.0420.0660.0470.0460.0460.050.05
Total Other Income Expenses Net -711.785-145.388-490.114-159.245-1,114.826-230.584-767.316-386.695-1,001.869-600.027-1,789.846264.278-715.512-546.231-227.424-477.723-20.909-259.358-212.276383.304295.424355.666355.666522.188261.094
Income Before Tax 4,132.6867,419.9043,762.6816,876.3593,071.8666,395.2033,071.5435,023.2922,454.3864,414.27758.6465,740.5054,072.0155,110.4624,162.3814,419.9673,813.8914,228.7742,957.7895,092.5062,012.5743,461.3873,461.3873,456.4571,728.228
Income Before Tax Ratio 0.030.0530.0290.0490.0240.0510.0250.0440.0220.0490.0070.0560.0420.0550.0460.0530.0470.0560.0390.0710.0550.0510.0510.0590.059
Income Tax Expense 1,086.5851,631.417894.3391,423.679599.6371,412.765689.5071,071.519910.039841.828416.9541,124.811562.4741,047.679748.646966.8361,026.3121,048.264737.1751,230.886492.015715.451715.451729.143364.572
Net Income 793.8512,822.631,206.3723,038.061,122.3663,025.0461,330.7832,438.106719.9322,577.194251.0493,035.371,727.9762,249.6271,672.5891,810.4471,185.3411,636.069568.4122,281.6641,520.5592,745.9362,745.9362,727.3141,363.657
Net Income Ratio 0.0060.020.0090.0220.0090.0240.0110.0210.0060.0290.0020.030.0180.0240.0190.0220.0150.0220.0080.0320.0410.040.040.0470.047
EPS 0.120.450.190.480.180.480.210.390.110.410.040.480.270.360.270.290.230.350.120.490.250.440.440.440.22
EPS Diluted 0.120.450.190.480.180.480.210.390.110.410.040.480.270.360.270.290.230.350.120.490.250.440.440.440.22
EBITDA 6,104.78310,460.5665,696.81410,205.8616,111.9979,361.2155,779.6447,860.3485,293.5847,172.3983,994.6548,581.7456,708.5937,111.0376,034.4566,127.4515,241.0255,931.5293,848.0065,298.7312,053.6123,782.1223,782.1223,532.1171,766.059
EBITDA Ratio 0.0440.0750.0440.0730.0480.0740.0470.0690.0480.080.0390.0840.070.0760.0670.0740.0650.0780.0510.0740.0560.0560.0560.060.06